CME Group Inc. (CME)
NASDAQ: CME · Real-Time Price · USD
276.70
+0.88 (0.32%)
At close: Jul 3, 2025, 1:00 PM
275.84
-0.86 (-0.31%)
After-hours: Jul 3, 2025, 3:32 PM EDT
CME Group Stock Forecast
Stock Price Forecast
The 16 analysts that cover CME Group stock have a consensus rating of "Hold" and an average price target of $259.44, which forecasts a -6.24% decrease in the stock price over the next year. The lowest target is $198 and the highest is $305.
Price Target: $259.44 (-6.24%)
Analyst Consensus: Hold
Analyst Ratings
The average analyst rating for CME Group stock is "Hold". This means that analysts believe this stock is likely to perform similarly to the overall market.
Recommendation Trends
| Rating | Feb '25 | Mar '25 | Apr '25 | May '25 | Jun '25 | Jul '25 |
|---|---|---|---|---|---|---|
| Strong Buy | 1 | 0 | 1 | 1 | 1 | 1 |
| Buy | 3 | 4 | 5 | 5 | 5 | 5 |
| Hold | 8 | 8 | 7 | 7 | 7 | 7 |
| Sell | 2 | 2 | 2 | 2 | 2 | 2 |
| Strong Sell | 2 | 2 | 2 | 2 | 1 | 1 |
| Total | 16 | 16 | 17 | 17 | 16 | 16 |
Latest Forecasts
| Analyst | Firm | Rating | Rating | Action | Price Target | Upside | Date |
|---|---|---|---|---|---|---|---|
| Citigroup | Citigroup | Hold Maintains $265 → $275 | Hold | Maintains | $265 → $275 | -0.61% | Jul 3, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $282 → $300 | Buy | Maintains | $282 → $300 | +8.42% | Jun 4, 2025 |
| UBS | UBS | Strong Buy Maintains $290 → $305 | Strong Buy | Maintains | $290 → $305 | +10.23% | Apr 25, 2025 |
| Oppenheimer | Oppenheimer | Buy Maintains $279 → $282 | Buy | Maintains | $279 → $282 | +1.92% | Apr 24, 2025 |
| Morgan Stanley | Morgan Stanley | Buy Maintains $301 → $304 | Buy | Maintains | $301 → $304 | +9.87% | Apr 24, 2025 |
Financial Forecast
Revenue This Year
6.69B
from 6.12B
Increased by 9.26%
Revenue Next Year
6.96B
from 6.69B
Increased by 4.04%
EPS This Year
11.30
from 9.67
Increased by 16.84%
EPS Next Year
11.76
from 11.30
Increased by 4.12%
Historical EPS numbers are GAAP, while forecasted numbers may be non-GAAP.
Revenue Forecast
| Revenue | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 7.5B | 7.9B | 8.4B | ||
| Avg | 6.7B | 7.0B | 7.3B | ||
| Low | 6.2B | 6.3B | 6.6B |
Revenue Growth
| Revenue Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 22.5% | 18.9% | 21.3% | ||
| Avg | 9.3% | 4.0% | 5.3% | ||
| Low | 2.1% | -5.6% | -4.8% |
EPS Forecast
| EPS | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 12.86 | 13.28 | 14.31 | ||
| Avg | 11.30 | 11.76 | 12.61 | ||
| Low | 10.33 | 10.33 | 11.17 |
EPS Growth
| EPS Growth | 2025 | 2026 | 2027 | 2028 | 2029 |
|---|---|---|---|---|---|
| High | 33.0% | 17.6% | 21.7% | ||
| Avg | 16.8% | 4.1% | 7.2% | ||
| Low | 6.8% | -8.6% | -5.0% |
Sources: Price targets and analyst ratings provided by Benzinga. Revenue and EPS forecast data provided by Finnhub. The data is sourced from Wall Street analysts. Data disclaimer.